:: Library Catalog

Imagen de Portada

Guardado en:

Detalles Bibliográficos
Autores principales:	Katie B. Olney, Joel I. Howard, David S. Burgess
Formato:	Artículo Open Access
Publicado:	Wiley 2024
Materias:	The Journal of Clinical Pharmacology
Acceso en línea:	https://accp1.onlinelibrary.wiley.com/doi/10.1002/jcph.2425
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Physiologically Based Pharmacokinetic/Pharmacodynamic Model for Secukinumab: Dose Exploration in Pediatric Patients with Plaque Psoriasis
por: Liu Zhiwei, et al.
Publicado: (2025)

Indomethacin Pharmacokinetics and Pharmacodynamics in Pregnancies With Preterm Labor: The Need for Dose‐Ranging Trials
por: Stephen J. Balevic, et al.
Publicado: (2024)

A Randomized, Parallel, Open‐Label, Single‐Dose and Multiple‐Dose Clinical Trial to Investigate the Pharmacokinetic, Pharmacodynamic, and Safety Profiles of Obicetrapib in Healthy Participants in China
por: Jing Zhang, et al.
Publicado: (2024)

Dose Optimization of BIIB107, an Anti‐Alpha‐4 Integrin Monoclonal Antibody, Through Population Pharmacokinetic and Pharmacodynamic Modeling
por: Marie Toukam, et al.
Publicado: (2025)

Pharmacokinetics‐Based Pediatric Dose Evaluation and Optimization Using Saliva – A Case Study
por: Marion Anliker‐Ort, et al.
Publicado: (2024)

Population Pharmacokinetics and Dosing Simulations of Pentobarbital in the Pediatric Population
por: Victoria Etges Helfer, et al.
Publicado: (2026)

Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous and Intravenous Garadacimab Following Single‐Dose Administration in Healthy Japanese and White Adults
por: Fiona Glassman, et al.
Publicado: (2024)

Population Pharmacokinetics (PopPK) Support for Pediatric Dosing of Biological Products
por: Brianna Eales, et al.
Publicado: (2024)

Physiologically based Pharmacokinetic/Pharmacodynamic Modeling (PBPK/PD) of Famotidine in Pregnancy
por: Xiaomei I. Liu, et al.
Publicado: (2025)

Physiologically Based Pharmacokinetic Modeling and Pharmacodynamic Target Attainment Analysis for Ceftriaxone Dosing in Pregnant Women: Model Development and Clinical Applications
por: Xinyue Chen, et al.
Publicado: (2026)

Guiding Dyslipidemia Treatment: A Population Pharmacokinetic–Pharmacodynamic Framework for Obicetrapib
por: Allison Dunn, et al.
Publicado: (2024)

A Phase I Study of the Pharmacokinetics, Pharmacodynamics, and Safety of Liposomal Bupivacaine for Sciatic Nerve Block in the Popliteal Fossa for Bunionectomy
por: Daniel I. Sessler, et al.
Publicado: (2024)

Safety, Pharmacokinetics, and Pharmacodynamics of the New Aldose Reductase Inhibitor Govorestat (AT‐007) After a Single and Multiple Doses in Participants in a Phase 1/2 Study
por: Riccardo Perfetti, et al.
Publicado: (2024)

Crossing the Chasm: How to Approach Translational Pharmacokinetic–Pharmacodynamic Modeling of Phage Dosing
por: Gauri G. Rao, et al.
Publicado: (2024)

Pharmacokinetic and Pharmacodynamic Modeling Analysis of Delpazolid (LCB01‐0371) in Adult Patients with Pulmonary Tuberculosis
por: Sang Min Lee, et al.
Publicado: (2024)

Pharmacokinetic, Pharmacodynamic, and Safety Profiles of Proline Henagliflozin in Chinese Subjects with Varying Degrees of Liver Dysfunction
por: Likun Ding, et al.
Publicado: (2024)

Comparing the Efficacy of Various Insulin Types: Pharmacokinetic and Pharmacodynamic Modeling of Glucose Clamp Effects in Healthy Volunteers
por: Yi Chien Chang, et al.
Publicado: (2025)

Population Pharmacokinetics and Loading Dose Optimization of Intravenous Valproic Acid in Hospitalized Thai Patients
por: Sirima Sitaruno, et al.
Publicado: (2024)

Population Pharmacokinetics and Dosing Optimization of Piperacillin in Elderly Patients with Pneumonia in the Intensive Care Unit
por: Jing Sun, et al.
Publicado: (2025)

Effect of Hepatic Impairment on the Pharmacokinetics and Pharmacodynamics of SHR4640, a Selective Human Urate Transporter 1 Inhibitor
por: Xiaotong Hu, et al.
Publicado: (2024)

Dried Blood Spots Sampling and Population Pharmacokinetic Modeling for Dosing Optimization of Piperacillin in Chinese Neonates
por: Pei Li, et al.
Publicado: (2024)

Safety, Pharmacokinetics, and Pharmacodynamics of Etrasimod: Single and Multiple Ascending Dose Studies in Healthy Adults
por: Caroline A. Lee, et al.
Publicado: (2024)

Population Pharmacokinetics to Support Intravenous and Enteral Methadone Dosing in Children
por: Kevin M. Watt, et al.
Publicado: (2025)

Optimizing Linezolid Dosing in Lung Transplant Recipients: Population Pharmacokinetics, Target Attainment, and Thrombocytopenia Risk Assessment
por: Dan Zhang, et al.
Publicado: (2026)

Physiologically Based Pharmacokinetic Modeling to Predict Maternal Pharmacokinetic Changes of Topiramate During Pregnancy and Recommend Dose Adjustments
por: Yuying Chen, et al.
Publicado: (2025)

Randomized, Placebo‐Controlled, First‐in‐Human Study of the Safety, Tolerability, and Pharmacokinetics of Single and Repeat Oral Doses of Novel Antitubercular Drug Candidate, GSK2556286, in Healthy Adults
por: Emma Ilsley, et al.
Publicado: (2026)

Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Studies Related to Vincristine‐Induced Peripheral Neuropathy in Chinese Pediatric ALL Patients
por: Yawen Yuan, et al.
Publicado: (2024)

Population Pharmacokinetic Simulations for Dose Optimization of Tenofovir Disoproxil Fumarate in HIV‐Infected Patients with Moderate‐to‐Severe Renal Impairment
por: Apinya Boonpeng, et al.
Publicado: (2024)

Physiologically Based Pharmacokinetic Modeling of Lemborexant: Exploration of Doses for Populations with Hepatic Impairment
por: Wanhong Wu, et al.
Publicado: (2025)

Physiologically Based Pharmacokinetic Modeling of Lurasidone, an Antipsychotic Drug: Impact of CYP3A4 Polymorphisms and Hepatic Impairment on Exposure and Dose Optimization
por: Seung‐Hyun Jeong, et al.
Publicado: (2026)

Dose Ranging in Pediatric Drug Development Trials Submitted to the US FDA 2012–2020
por: Carlton K. K. Lee, et al.
Publicado: (2025)

Population Pharmacokinetics of Caffeine in Infants with Hypoxic‐Ischemic Encephalopathy: A Phase I, Dose‐Escalating Trial
por: Elizabeth J Thompson, et al.
Publicado: (2025)

Evaluating Tranexamic Acid Dosing Strategies for Postpartum Hemorrhage: A Population Pharmacokinetic Approach in Pregnant Individuals
por: Allison Dunn, et al.
Publicado: (2025)

Characterizing the Nonlinear Pharmacokinetics and Pharmacodynamics of BI 187004, an 11β‐Hydroxysteroid Dehydrogenase Type 1 Inhibitor, in Humans by a Target‐Mediated Drug Disposition Model
por: Xuanzhen Yuan, et al.
Publicado: (2024)

External Evaluation of Population Pharmacokinetic Models for High‐Dose Methotrexate in Adult Patients with Hematological Tumors
por: Shengyang Chen, et al.
Publicado: (2024)

Pooled Population Pharmacokinetic Analysis and Dose Recommendations for Ciprofloxacin in Intensive Care Unit Patients with Obesity
por: Koen P. van Rhee, et al.
Publicado: (2024)

Physiologically Based Pharmacokinetic Modeling of Caffeine in Preterm Neonates: Influence of Renal Function and Impairment on Dosing
por: Nolan Thomas, et al.
Publicado: (2025)

Clinical Impact of Hepatic Impairment on the Pharmacokinetics of Sotorasib and Its Major Metabolites: Implications for Dose Adjustment
por: Mason McComb, et al.
Publicado: (2025)

Predicting Clinical Pharmacokinetics/Pharmacodynamics and Impact of Organ Impairment on siRNA‐Based Therapeutics Using a Mechanistic Physiologically‐Based Pharmacokinetic‐Pharmacodynamic Model
por: Annie Lumen, et al.
Publicado: (2024)

A Phase 1, Open‐Label, Single Ascending (Two Levels) Dose Study to Evaluate the Pharmacokinetics of Vorasidenib in Healthy Japanese and Non‐Asian Participants
por: Tharin Limsakun, et al.
Publicado: (2026)